Treating acute stroke patients with intravenous tPA: The OSF Stroke Network experience

Stroke

Volumn 31, Issue 1, 2000, Pages 77-81

  Wang, David Z ^a,b,c   Rose, Jean A ^a   Honings, Debra S ^a   Garwacki, Dennis J ^a,b   Milbrandt, Joseph C ^a,b  

^a OSF SAINT FRANCIS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c OSF Stroke Network   (United States)

Author keywords

Stroke, ischemic; Thrombolysis; Tissue plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; HEALTH PROGRAM; HUMAN; MALE; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

EID: 0033962916     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.1.77     Document Type: Article

References (13)

1. National Institute of Neurological Diseases and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Chiu D, Krieger D, Villa-Cordova C, Kasner SE, Morgenstern LB, Bratina PL, Yatsu FM, Grotta JC. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke. 1998;29:18-22.
3. Hickenbottom SL, Morgenstern LB. Physician response to rt-PA two years after approval: attitudes, barriers to adoption, and potential solutions. Stroke Intervent. 1998;1:3-5.
4. Anderson A, Smith DB, Hughes RL. The Colorado Acute Stroke Network experience with intravenous rt-PA in acute ischemic stroke. Neurology. 1998;50:A157. Abstract.
5. Dafer RM, Tiejen GE, Korsnack A. Experience with rt-PA at a small medical center. Neurology. 1998;50:A115. Abstract.
6. Cruz-Flores S, Thompson DW, Banet G, Burch CM, Parks BJ, Selhorst JB, Shulman S. Intravenous thrombolysis in acute ischemic stroke: preliminary experience with tissue plasminogen activator. Neurology. 1998; 50:A113-A114. Abstract.
7. Adams HP, Brott TG, Furland AJ, Gomez CR, Helgason CM, Kwiatkowski T, Lyden PD, Marier JR, Torner J, Feinberg W, Mayberg M, Thies W. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation. 1996;94:1167-1174.
8. Adams HP, Bendixen BH, Rappelle LJ, Biller J, Love BB, Gordon DL, March EE, for the TOAST Investigators. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke. 1993;24:35-41.
9. Lyden P, Brott T, Tilley BC, Welch KMA, Mascha EJ, Levine SR, Haley EC, Grotta J, Marier J, for the NINDS rt-PA Stroke Study Investigators. Improved reliability of the NIH Stroke Scale using video training. Stroke. 1994;25:2220-2226.
10. Tilley BD, Lyden PD, Brott TG, Lu M, Levine SR, Welch KMA, for the NINDS rt-PA Stroke Group. Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. Arch Neurol. 1997;54:1466-1474.
11. NSA Stroke Center Network recommendations. J Stroke Cerebrovasc Dis. 1997;6:299-303.
12. The NINDS rt-PA Stroke Study Group. A systems approach to immediate evaluation and management of hyperacute stroke: experience at 8 centers and implications for community practice and patient care. Stroke. 1997; 28:1530-1540.
13. Marler JR, Winter Jones P, Emr M, eds. Proceedings of National Symposium on Rapid Identification and Treatment of Acute Stroke. Bethesda, Md: National Institute of Neurological Disorders and Stroke, National Institutes of Health; August 1997. NIH publication 97-4239.